RXI PHARMACEUTICALS


Updates from The Motley Fool

Latest updates on RXi Pharmaceuticals from Fool.com.

There is no available coverage of RXi Pharmaceuticals at this time.



Stock Performance

RXII vs. S&P 500 | 2 Year Performance
View Interactive RXII Charts
Sponsored by

Key Data Points

Primary metrics and data points about RXi Pharmaceuticals.
Current Price: $2.35
Prev Close: $2.37
Open: $2.35
Bid: $0.00
Ask: $2.72
Day's Range: $2.32 - $2.42
52wk Range: $1.26 - $6.49
Volume: 33,111
Avg Vol 105,810
Market Cap: $153.57M
P/E (ttm): -0.34
EPS (ttm): -$6.92
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about RXi Pharmaceuticals.
CAPS Rating 2 out of 5
 
190 Outperform
20 Underperform
CAPS All Stars
 
22 Outperform
8 Underperform

How do you think RXi Pharmaceuticals will perform against the market?



You pick for RXi Pharmaceuticals is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Noah D. Beerman, CEO

0% Approve

Based on 0 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for RXi Pharmaceuticals.

RXI PHARMACEUTICALS

  • Exchange: NASDAQ